Mon, Dec 22, 2014, 3:37 AM EST - U.S. Markets open in 5 hrs 53 mins


% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • beameup_999 beameup_999 Nov 2, 2011 8:40 PM Flag

    From a Nov. 2nd Publication About Biocon

    Significant numbers from Fidaxomicin supplies for Biocon are expected in FY2013E.
    Recently Optimer increased its peak sales forecast to US$2 bn from US$1.5 bn earlier.
    Biocon has also tied up as the exclusive supplier for Europe where launch is planned in
    2012E with Astellas as marketing partner. Optimer received positive response from CHMP
    (Committee for Medicinal Products for Human Use) in September 2011. The European
    Commission generally follows the recommendations of the CHMP and delivers its final
    decision within three months of the CHMP opinion.

12.780.0000(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.